NCT00924898View on ClinicalTrials.gov

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Acute HIV InfectionHIV Infections
Interventions
DRUG

efavirenz, emtricitabine, and tenofovir

Once daily ART with emtricitabine, tenofovir DF and efavirenz

Trial Locations (2)

27599

The University of North Carolina - Chapel Hill, Chapel Hill

27707

Duke University, Durham

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER